Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Industry Dynamics, Trends and Scope
2.1. Industry Dynamics
2.1.1. Industry driver analysis
2.1.1.1. Expanding applications of dental implants in various therapeutic areas
2.1.1.2. Introduction of novel implants
2.1.1.3. Increasing demand for prosthetics
2.1.1.4. Rising adoption of preventive and restorative dental care by the geriatric population
2.1.2. Industry restraint analysis
2.1.2.1. Higher cost of dental implant procedure
2.1.3. Industry opportunity analysis
2.1.3.1. Rising demand for aesthetic dentistry
2.1.3.2. Expanding adoption in emerging markets
2.1.4. Industry challenge analysis
2.1.4.1. Intense Market Competition
2.2. Industry Analysis Tools
2.2.1. Industry Analysis - Porter’s
2.2.1.1. Bargaining power of suppliers
2.2.1.2. Bargaining power of buyers
2.2.1.3. Threat of substitutes
2.2.1.4. Threat of new entrants
2.2.1.5. Competitive rivalry
2.2.2. PESTEL Analysis
2.2.2.1. Political & Legal Landscape
2.2.2.2. Economic and Social Landscape
2.2.2.3. Technological landscape
Chapter 3. Competitive Landscape
3.1. Recent Developments & Impact Analysis, By Key Market Participants
3.2. Company/Competition Categorization
3.2.1. Innovators
3.3. Vendor Landscape
3.3.1. List of key distributors and channel partners
3.3.2. Global Key company market share analysis, 2024
3.3.2.1. Dentsply Sirona
3.3.2.1.1. Company overview
3.3.2.1.2. Financial performance
3.3.2.1.3. Product benchmarking
3.3.2.1.4. Strategic initiatives
3.3.2.2. Institut Straumann AG
3.3.2.2.1. Company overview
3.3.2.2.2. Financial performance
3.3.2.2.3. Product benchmarking
3.3.2.2.4. Strategic initiatives
3.3.2.3. Nobel Biocare Services AG (Envista)
3.3.2.3.1. Company overview
3.3.2.3.2. Financial performance
3.3.2.3.3. Product benchmarking
3.3.2.3.4. Strategic initiatives
3.3.2.4. ZimVie Inc.
3.3.2.4.1. Company overview
3.3.2.4.2. Financial performance
3.3.2.4.3. Product benchmarking
3.3.2.4.4. Strategic initiatives
3.3.2.5. BioHorizons
3.3.2.5.1. Company overview
3.3.2.5.2. Financial performance
3.3.2.5.3. Product benchmarking
3.3.2.5.4. Strategic initiatives
3.3.2.6. DentiumUSA
3.3.2.6.1. Company overview
3.3.2.6.2. Financial performance
3.3.2.6.3. Product benchmarking
3.3.2.6.4. Strategic initiatives
3.3.2.7. Neoss
3.3.2.7.1. Company overview
3.3.2.7.2. Financial performance
3.3.2.7.3. Product benchmarking
3.3.2.7.4. Strategic initiatives
3.3.2.8. OSSTEM IMPLANT
3.3.2.8.1. Company overview
3.3.2.8.2. Financial performance
3.3.2.8.3. Product benchmarking
3.3.2.8.4. Strategic initiatives
3.3.2.9. Bicon
3.3.2.9.1. Company overview
3.3.2.9.2. Financial performance
3.3.2.9.3. Product benchmarking
3.3.2.9.4. Strategic initiatives
3.3.2.10. LeaderMedica SRL
3.3.2.10.1. Company overview
3.3.2.10.2. Financial performance
3.3.2.10.3. Product benchmarking
3.3.2.10.4. Strategic initiatives
3.3.2.11. DENTIS Co., Ltd.
3.3.2.11.1. Company overview
3.3.2.11.2. Financial performance
3.3.2.11.3. Product benchmarking
3.3.2.11.4. Strategic initiatives
3.3.2.12. T-Plus Tech (Institut Straumann AG)
3.3.2.12.1. Company overview
3.3.2.12.2. Financial performance
3.3.2.12.3. Product benchmarking
3.3.2.12.4. Strategic initiatives
3.3.2.13. KYOCERA Medical Corporation (KYOCERA Corporation)
3.3.2.13.1. Company overview
3.3.2.13.2. Financial performance
3.3.2.13.3. Product benchmarking
3.3.2.13.4. Strategic initiatives
3.3.2.14. Double Medical Technology Inc.
3.3.2.14.1. Company overview
3.3.2.14.2. Financial performance
3.3.2.14.3. Product benchmarking
3.3.2.14.4. Strategic initiatives
3.3.2.15. Bioconcept (BASS Medical Group)
3.3.2.15.1. Company overview
3.3.2.15.2. Financial performance
3.3.2.15.3. Product benchmarking
3.3.2.15.4. Strategic initiatives
3.3.2.16. SOUTHERN IMPLANTS
3.3.2.16.1. Company overview
3.3.2.16.2. Financial performance
3.3.2.16.3. Product benchmarking
3.3.2.16.4. Strategic initiatives